Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
223 studies found for:    "Ependymoma"
Show Display Options
Rank Status Study
1 Terminated Carboplatin as a Radiosensitizer in Treating Childhood Ependymoma
Condition: Ependymoma
Intervention: Drug: Carboplatin
2 Recruiting Everolimus for Children With Recurrent or Progressive Ependymoma
Condition: Recurrent Childhood Ependymoma
Intervention: Drug: Everolimus
3 Recruiting A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma
Condition: Ependymoma
Interventions: Radiation: Irradiation;   Procedure: Surgery
4 Recruiting Immunotherapy for Recurrent Ependymomas in Children Treatment for Recurrent Ependymomas Using HLA-A2 Restricted Tumor Antigen Peptides in Combination With Imiquimod
Condition: Ependymoma
Interventions: Biological: HLA-A2 restricted synthetic tumor antigen;   Drug: Imiquimod;   Other: enzyme-linked immunosorbent assay;   Other: flow cytometry;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis
5 Recruiting An International Clinical Program for the Diagnosis and Treatment of Children With Ependymoma
Condition: Childhood Ependymoma
Interventions: Drug: 16 weeks of VEC + CDDP;   Drug: VEC + HD-MTX;   Drug: Chemotherapy + Valproate;   Radiation: Conformal radiotherapy;   Drug: VEC;   Drug: Chemotherapy;   Radiation: conformal radiotherapy +/- boost
6 Recruiting Carboplatin and Bevacizumab for Recurrent Ependymoma
Conditions: Ependymoma;   Anaplastic Ependymoma
Interventions: Drug: Carboplatin;   Drug: Bevacizumab
7 Terminated
Has Results
Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma
Condition: Recurrent or Refractory Pediatric Ependymoma
Interventions: Drug: erlotinib;   Drug: etoposide
8 Not yet recruiting Pilot Study of the Effect of Trastuzumab and GM-CSF on Children With Recurrent Ependymoma
Condition: Posterior Fossa Ependymoma (PFEPN)
Interventions: Drug: Trastuzumab after SubQ GM-CSF;   Drug: Trastuzumab in combination with SubQ GM-CSF
9 Completed Adult Intracranial Ependymoma
Condition: Intracranial Ependymoma
Intervention: Other: tumoral sample
10 Completed Phase I Study of 5-Fluorouracil in Children and Young Adults With Recurrent Ependymoma
Conditions: Central Nervous System Malignancies;   Ependymoma
Intervention: Drug: 5-fluorouracil
11 Terminated
Has Results
Single-agent Erlotinib in Patients Previously Treated With Oral Etoposide in Protocol OSI-774-205
Condition: Ependymoma
Intervention: Drug: Erlotinib
12 Completed Study of Tumor Samples From Patients With Ependymoma Treated on the Children's Oncology Group ACNS0121 Trial
Conditions: Childhood Infratentorial Ependymoma;   Childhood Supratentorial Ependymoma;   Newly Diagnosed Childhood Ependymoma
Intervention: Other: laboratory biomarker analysis
13 Recruiting Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma
Conditions: Childhood Infratentorial Ependymoma;   Childhood Supratentorial Ependymoma;   Newly Diagnosed Childhood Ependymoma
Interventions: Drug: liposomal vincristine sulfate;   Other: clinical observation;   Radiation: 3-dimensional conformal radiation therapy;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: etoposide;   Drug: cisplatin;   Other: laboratory biomarker analysis
14 Not yet recruiting Infusion of 5-Azacytidine (5-AZA) Into the Fourth Ventricle in Children With Recurrent Posterior Fossa Ependymoma
Condition: Brain Tumor Recurrent
Intervention: Drug: 5-Azacytidine
15 Completed Multicenter Register for Children and Young Adults With Intracranial Localized Medulloblastoma, CNS-PNET or Ependymoma
Conditions: Medulloblastoma, Childhood;   Cerebral Primitive Neuroectodermal Tumor;   Ependymoma
Intervention:
16 Unknown  Etoposide in Treating Young Patients With Relapsed Ependymoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: etoposide;   Procedure: conventional surgery
17 Unknown  High-Dose Methotrexate in Treating Young Patients With Residual Ependymoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: methotrexate;   Procedure: adjuvant therapy
18 Completed Combination Chemotherapy Followed by Radiation Therapy in Treating Children With Localized Ependymoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: cyclophosphamide;   Drug: etoposide;   Drug: vincristine sulfate;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Radiation: radiation therapy
19 Completed Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma
Conditions: Brain Cancer;   Pediatric Cancers
Interventions: Drug: Bevacizumab;   Drug: Lapatinib
20 Completed Etoposide Plus Cisplatin in Treating Patients With Recurrent Ependymomas
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: cisplatin;   Drug: etoposide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.